Definium Therapeutics, Inc. (DFTX)
16.23
-1.12
(-6.46%)
USD |
NASDAQ |
Feb 12, 16:00
16.41
+0.18
(+1.11%)
After-Hours: 04:47
Definium Therapeutics Shareholders Equity (Quarterly) : 130.60M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Pulse Biosciences, Inc. | 92.69M |
| RxSight, Inc. | 275.97M |
| Plus Therapeutics, Inc. | 5.054M |
| Viridian Therapeutics, Inc. | 502.97M |
| Nutriband, Inc. | 7.549M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 236.92M |
| Total Liabilities (Quarterly) | 106.32M |
| Debt to Equity Ratio | 0.3092 |
| Current Ratio | 3.300 |
| Net Debt Paydown Yield | -0.36% |